- RenovoRx Chief Executive Officer and director Shaun Bagai reported the purchase of 24,300 shares of common stock.
- The transaction totaled USD 25,000.
- Following the reported transaction, The Bagai Family Trust beneficially owned 313,357 shares indirectly.
- A warrant position for 12,150 shares was reported with an exercise price of USD 1.93.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-012482), on March 24, 2026, and is solely responsible for the information contained therein.
Comments